Advertisement
Screener

ENVOY MEDICAL, INC. (COCH) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ENVOY MEDICAL, INC. Operating Cash Flow

ENVOY MEDICAL, INC. (COCH) reported Operating Cash Flow of -$11.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10

  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.46M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.06M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.68M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.33M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$17.09M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$8.80M.
  • ENVOY MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$3.24M.
Period endNet Cash Provided by (Used in) Operating Activities 0 monthNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$5.46M
derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10
-$11.52M
10-Q · filed 2026-08-10
-$17.20M
derived: sum of 3 quarters · filed 2026-08-10
-$21.53M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$6.06M
POS AM · filed 2026-06-12
-$11.75M
derived: sum of 2 quarters · filed 2026-06-12
-$16.08M
derived: sum of 3 quarters · filed 2026-06-12
-$20.54M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$5.68M
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
-$10.02M
derived: sum of 2 quarters · filed 2026-06-12
-$14.48M
derived: sum of 3 quarters · filed 2026-08-10
-$18.20M
POS AM · filed 2026-06-12
2025-09-30-$4.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$8.79M
derived: sum of 2 quarters · filed 2026-08-10
-$12.52M
10-Q · filed 2025-11-10
-$17.61M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$4.46M
derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10
-$8.19M
10-Q · filed 2026-08-10
-$13.28M
derived: sum of 3 quarters · filed 2026-08-10
-$15.90M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$3.73M
POS AM · filed 2026-06-12
-$8.82M
derived: sum of 2 quarters · filed 2026-06-12
-$11.44M
derived: sum of 3 quarters · filed 2026-06-12
-$16.09M
derived: sum of 4 quarters · filed 2026-06-12
2024-12-31-$5.09M
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
-$7.71M
derived: sum of 2 quarters · filed 2026-06-12
-$12.36M
derived: sum of 3 quarters · filed 2026-06-12
-$17.95M
POS AM · filed 2026-06-12
2024-09-30-$2.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$7.27M
derived: sum of 2 quarters · filed 2025-11-10
-$12.86M
10-Q · filed 2025-11-10
-$13.56M
10-Q · filed 2024-11-14
-$24.00M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$4.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$10.23M
10-Q · filed 2025-07-31
-$10.75M
10-Q · filed 2024-08-12
-$21.38M
derived: sum of 3 quarters · filed 2025-07-31
-$20.28M
derived: sum of 4 quarters · filed 2025-07-31
2024-03-31-$5.59M
10-Q · filed 2025-05-01
-$5.85M
10-Q · filed 2024-05-15
-$16.73M
derived: sum of 2 quarters · filed 2025-05-01
-$15.63M
derived: sum of 3 quarters · filed 2025-05-01
-$19.67M
derived: sum of 4 quarters · filed 2025-05-01
2023-12-31-$11.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$10.05M
derived: sum of 2 quarters · filed 2025-03-31
-$14.08M
derived: sum of 3 quarters · filed 2025-03-31
-$17.09M
10-K · filed 2025-03-31
-$17.65M
10-K · filed 2024-04-01
2023-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$2.94M
derived: sum of 2 quarters · filed 2024-11-14
-$5.95M
10-Q · filed 2024-11-14
-$8.32M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$4.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$7.04M
10-Q · filed 2024-08-12
-$2.86M
10-Q · filed 2023-08-14
-$9.42M
derived: sum of 3 quarters · filed 2024-08-12
-$14.68M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$3.01M
10-Q · filed 2024-05-15
-$2.18M
10-Q · filed 2023-05-15
-$5.39M
derived: sum of 2 quarters · filed 2024-05-15
-$10.64M
derived: sum of 3 quarters · filed 2024-05-15
-$11.04M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$2.38M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01
-$7.63M
derived: sum of 2 quarters · filed 2024-04-01
-$8.03M
derived: sum of 3 quarters · filed 2024-04-01
-$8.80M
10-K · filed 2024-04-01
-$2.66M
10-K · filed 2023-04-03
2022-09-30-$5.25M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-01-17
-$5.65M
derived: sum of 2 quarters · filed 2024-01-17
-$6.43M
10-Q/A · filed 2024-01-17
-$1.81M
10-Q · filed 2022-11-14
-$7.31M
derived: sum of 4 quarters · filed 2024-01-17
2022-06-30-$400.16K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$1.17M
10-Q · filed 2023-08-14
-$2.06M
derived: sum of 3 quarters · filed 2023-08-14
-$2.76M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$772.74K
10-Q · filed 2023-05-15
-$1.66M
derived: sum of 2 quarters · filed 2023-05-15
-$2.36M
derived: sum of 3 quarters · filed 2023-05-15
-$2.76M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$885.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-03
-$1.59M
derived: sum of 2 quarters · filed 2023-04-03
-$1.99M
derived: sum of 3 quarters · filed 2023-04-03
-$3.24M
10-K · filed 2023-04-03
2021-09-30-$701.35K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$1.11M
derived: sum of 2 quarters · filed 2022-11-14
-$2.36M
10-Q · filed 2022-11-14
2021-06-30-$405.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$1.65M
10-Q · filed 2022-08-15
2021-03-31-$1.25M
10-Q · filed 2022-05-16
2020-12-31$0.00
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALPHA PRO TECH LTD (APT)$0.052B13.63
MYOMO, INC. (MYO)United States$0.065B-2.85
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Safe Pro Group Inc. (SPAI)United States$0.090B
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Bone Biologics Corp (BBLG)United States$0.001B
Conexeu Sciences Inc. (CNXU)United States$0.111B